• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替代肺癌筛查标准的制定和性能评估。

The Development and Performance of Alternative Criteria for Lung Cancer Screening.

机构信息

Center for Healthcare Organization & Implementation Research, VA Boston Healthcare System, and The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts (L.E.K.).

VA Ann Arbor Healthcare System and Center for Clinical Management Research, Ann Arbor, Michigan (P.B.).

出版信息

Ann Intern Med. 2024 Sep;177(9):1222-1232. doi: 10.7326/M23-3250. Epub 2024 Aug 20.

DOI:10.7326/M23-3250
PMID:39159457
Abstract

BACKGROUND

The recommendation for lung cancer screening (LCS) developed by the U.S. Preventive Services Task Force (USPSTF) may exclude some high-benefit people.

OBJECTIVE

To determine whether alternative criteria can identify these high-benefit people.

DESIGN

Model-based projections.

SETTING

United States.

PARTICIPANTS

People from the 1997-2014 National Health Interview Survey (NHIS) to develop alternative criteria using fast-and-frugal tree algorithms and from the 2014-2018 NHIS and the 2022 Behavioral Risk Factor Surveillance System for comparisons of USPSTF criteria versus alternative criteria.

MEASUREMENTS

Life-years gained from LCS were estimated using the life-years gained from screening computed tomography (LYFS-CT) model. "High-benefit" was defined as gaining an average of at least 16.2 days of life from 3 annual screenings, which reflects high lung cancer risk and substantial life gains if lung cancer is detected by screening.

RESULTS

The final alternative criteria were 1) people who smoked any amount each year for at least 40 years, or 2) people aged 60 to 80 years with at least 40 pack-years of smoking. The USPSTF and alternative criteria selected similar numbers of people for LCS. Compared with the USPSTF criteria, the alternative criteria had higher sensitivity (91% vs. 78%; < 0.001) and specificity (86% vs. 84%; < 0.001) for identifying high-benefit people. For racial and ethnic minorities, the alternative criteria provided greater gains in sensitivity than the USPSTF criteria (Black: 83% vs. 56% [ < 0.001]; Hispanic: 95% vs. 73% [ = 0.086]; Asian: 94% vs. 68% [ = 0.171]) at similar specificity. The alternative criteria identify high-risk, high-benefit groups excluded by the USPSTF criteria (those with a smoking duration of ≥40 years but <20 pack-years and a quit history of >15 years), many of whom are members of racial and ethnic minorities.

LIMITATION

The results were based on model projections.

CONCLUSION

These results suggest that simple alternative LCS criteria can identify substantially more high-benefit people, especially in some racial and ethnic groups.

PRIMARY FUNDING SOURCE

U.S. Department of Veterans Affairs Lung Precision Oncology Program.

摘要

背景

美国预防服务工作组(USPSTF)推荐的肺癌筛查(LCS)可能会排除一些高获益人群。

目的

确定是否可以使用替代标准来识别这些高获益人群。

设计

基于模型的预测。

设置

美国。

参与者

使用快速简易树算法从 1997 年至 2014 年国家健康访谈调查(NHIS)中确定替代标准,并从 2014 年至 2018 年 NHIS 和 2022 年行为风险因素监测系统中进行比较,以确定 USPSTF 标准与替代标准的差异。

测量

使用从筛查 CT(LYFS-CT)模型计算得出的筛查带来的生命年(LYFS-CT)来估计从 LCS 中获得的生命年。“高获益”被定义为通过每年三次筛查获得至少 16.2 天的平均寿命,如果通过筛查检测到肺癌,则可以获得较高的肺癌风险和显著的生命获益。

结果

最终的替代标准是:1)每年至少吸烟 40 年且吸烟量达到任何程度的人,或 2)年龄在 60 至 80 岁之间且吸烟量达到 40 包年的人。USPSTF 和替代标准选择了类似数量的人进行 LCS。与 USPSTF 标准相比,替代标准对高获益人群的敏感性(91%对 78%;<0.001)和特异性(86%对 84%;<0.001)更高。对于少数族裔,替代标准的敏感性提高幅度大于 USPSTF 标准(黑人:83%对 56%[<0.001];西班牙裔:95%对 73%[=0.086];亚裔:94%对 68%[=0.171]),特异性相似。替代标准确定了 USPSTF 标准排除的高危、高获益人群(吸烟年限≥40 年但<20 包年且戒烟史>15 年),其中许多人是少数族裔。

局限性

结果基于模型预测。

结论

这些结果表明,简单的替代 LCS 标准可以识别更多的高获益人群,特别是在某些种族和族裔群体中。

主要资金来源

美国退伍军人事务部肺部精准肿瘤学计划。

相似文献

1
The Development and Performance of Alternative Criteria for Lung Cancer Screening.替代肺癌筛查标准的制定和性能评估。
Ann Intern Med. 2024 Sep;177(9):1222-1232. doi: 10.7326/M23-3250. Epub 2024 Aug 20.
2
Reducing Smoking Requirements for Lung Screening to Address Health Disparities in a Community Cohort.降低肺部筛查的吸烟要求以解决社区队列中的健康差异。
JAMA Netw Open. 2025 Jun 2;8(6):e2517149. doi: 10.1001/jamanetworkopen.2025.17149.
3
Individual- and Group-Level Disparities Between Racial and Ethnic Groups in Lung Cancer Screening Eligibility Criteria.肺癌筛查资格标准中种族和族裔群体在个体及群体层面的差异。
JAMA Netw Open. 2025 Mar 3;8(3):e252172. doi: 10.1001/jamanetworkopen.2025.2172.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
7
Sexual Harassment and Prevention Training性骚扰与预防培训
8
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
9
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描(LDCT)筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
10
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.

引用本文的文献

1
Concordance-based Predictive Uncertainty (CPU)-Index: Proof-of-concept with application towards improved specificity of lung cancers on low dose screening CT.基于一致性的预测不确定性(CPU)指数:用于提高低剂量筛查CT对肺癌特异性的概念验证应用。
Artif Intell Med. 2025 Feb;160:103055. doi: 10.1016/j.artmed.2024.103055. Epub 2024 Dec 16.